Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

609 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial.
Uyl-de Groot CA, Vellenga E, de Vries EG, Löwenberg B, Stoter GJ, Rutten FF. Uyl-de Groot CA, et al. Among authors: lowenberg b. Pharmacoeconomics. 1997 Sep;12(3):351-60. doi: 10.2165/00019053-199712030-00007. Pharmacoeconomics. 1997. PMID: 10170460 Clinical Trial.
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.
Vellenga E, Uyl-de Groot CA, de Wit R, Keizer HJ, Löwenberg B, ten Haaft MA, de Witte TJ, Verhagen CA, Stoter GJ, Rutten FF, Mulder NH, Smid WM, de Vries EG. Vellenga E, et al. Among authors: lowenberg b. J Clin Oncol. 1996 Feb;14(2):619-27. doi: 10.1200/JCO.1996.14.2.619. J Clin Oncol. 1996. PMID: 8636779 Free article. Clinical Trial.
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
Löwenberg B, Boogaerts MA, Daenen SM, Verhoef GE, Hagenbeek A, Vellenga E, Ossenkoppele GJ, Huijgens PC, Verdonck LF, van der Lelie J, Wielenga JJ, Schouten HC, Gmür J, Gratwohl A, Hess U, Fey MF, van Putten WL. Löwenberg B, et al. J Clin Oncol. 1997 Dec;15(12):3496-506. doi: 10.1200/JCO.1997.15.12.3496. J Clin Oncol. 1997. PMID: 9396403 Clinical Trial.
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.
Löwenberg B, Suciu S, Archimbaud E, Ossenkoppele G, Verhoef GE, Vellenga E, Wijermans P, Berneman Z, Dekker AW, Stryckmans P, Schouten H, Jehn U, Muus P, Sonneveld P, Dardenne M, Zittoun R. Löwenberg B, et al. Blood. 1997 Oct 15;90(8):2952-61. Blood. 1997. PMID: 9376575 Free article. Clinical Trial.
609 results